-+ 0.00%
-+ 0.00%
-+ 0.00%

REMEPY RAISES $36 MILLION SERIES A TO EXPAND ITS HYBRID DRUG™ PIPELINE THROUGH PHARMACEUTICAL PARTNERSHIPS AND ADVANCE PHASE III OF HYBRIDOPA™ FOR PARKINSON'S DISEASE

Reuters·08/12/2026 12:30:36

Please log in to view news